Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced ...
This breakthrough, which is a first in the Triad, offers a new option for patients with severe tricuspid regurgitation, a ...
With the introduction of percutaneous options, the role of surgery in the repair of dysfunctional tricuspid valves is being reevaluated in an effort to reduce the risk for end-stage disease. In the ...
SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had “meaningful” improvements in ...
Surgeons at Gleneagles Hospitals successfully performed Transcatheter Tricuspid Valve Edge-to-Edge Repair on a 75-year-old ...
Patients with moderate tricuspid regurgitation (TR) undergoing surgery for mitral valve disease have a significant improvement in TR grade, according to the results of a new study. In early ...
An international study of more than 400 adults concludes that people who undergo mitral valve surgery (between the left atrium and the left ventricle of the heart) and also have less than severe ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the first transcatheter tricuspid valve replacement system. The system is indicated for ...
Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement plus medical therapy improved outcomes vs. medical therapy alone in ...
LONG BEACH, Calif., June 4, 2025 /PRNewswire/ -- The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., ...
Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...